Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Breast Cancer Patients Treated With Aromatase Inhibitors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT00382070
What this trial is testing

Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer

Who this might be right for
Breast Cancer
NSABP Foundation Inc 3,966
Testing effectiveness (Phase 2)Ended earlyNCT04227327
What this trial is testing

Study Evaluating Abemaciclib + Aromatase Inhibitors in HR+, HER2- Advanced Breast Cancer Patients (HERMIONE-7)

Who this might be right for
Advanced Breast Cancer
University of Milano Bicocca 31
Testing effectiveness (Phase 2)Study completedNCT03056755
What this trial is testing

Study Assessing the Efficacy and Safety of Alpelisib Plus Fulvestrant or Letrozole, Based on Prior Endocrine Therapy, in Patients With PIK3CA Mutant, HR+, HER2- Advanced Breast Cancer Who Have Progressed on or After Prior Treatments

Who this might be right for
Breast Cancer
Novartis Pharmaceuticals 383
Not applicableLooking for participantsNCT07215364
What this trial is testing

Impact of Exercise on Quality of Life of EBC Patients on Treatment With Adjuvant AI With or Without CDK4/6 Inhibitors

Who this might be right for
Early-stage Breast Cancer
Spanish Breast Cancer Research Group 74
Not applicableLooking for participantsNCT06650423
What this trial is testing

Adherence to Aromatase Inhibitors ± Abemaciclib Treatment in Patients With Early-stage HER2-negative Breast Cancer

Who this might be right for
Early Breast CancerHormone Receptor Positive TumorHER2-negative Breast Cancer
Institute of Oncology Ljubljana 319
Not applicableStudy completedNCT00769080
What this trial is testing

The Performance of Patient Support Program in Early Stage Breast Cancer

Who this might be right for
Breast Cancer
AstraZeneca 524
Not applicableStudy completedNCT01983995
What this trial is testing

Examining the Relationships Between Sleep, Fatigue, and Pain in Aromatase Inhibitor-treated Patients

Who this might be right for
Breast Cancer
University of Michigan 49
Not applicableStudy completedNCT00814034
What this trial is testing

Coagulation Parameters in Postmenopausal Breast Cancer Patients Under Adjuvant Hormonal Therapy

Who this might be right for
Breast Cancer
Hellenic Breast Surgeons Society 306
Not applicableStudy completedNCT05779566
What this trial is testing

Evaluation of the Functional/Emotional Life Characteristics of Ongoing EAT in BC Patients With Reduced BMD

Who this might be right for
Breast CancerOsteopenia
Fundación para la Investigación del Hospital Clínico de Valencia 82
Not applicableStudy completedNCT01720602
What this trial is testing

Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Hormone Therapy

Who this might be right for
Male Breast CancerRecurrent Breast CancerStage IV Breast Cancer
University of Washington 15
Testing effectiveness (Phase 2)UnknownNCT02530411
What this trial is testing

Fulvestrant +/- Vandetanib in Advanced Aromatase Inhibitor Resistant Breast Cancer

Who this might be right for
Neoplasms
Velindre NHS Trust 160
Large-scale testing (Phase 3)Study completedNCT01610284
What this trial is testing

Phase III Study of BKM120/Placebo With Fulvestrant in Postmenopausal Patients With Hormone Receptor Positive HER2-negative Locally Advanced or Metastatic Breast Cancer Refractory to Aromatase Inhibitor

Who this might be right for
Breast Cancer
Novartis Pharmaceuticals 1,147
Testing effectiveness (Phase 2)WithdrawnNCT03666819
What this trial is testing

Carbon Dioxide Fractional Laser in Treating Participants With Stage 0-III Hormone Receptor-Positive Breast Cancer With Vulvovaginal Atrophy

Who this might be right for
Anatomic Stage 0 Breast Cancer AJCC v8Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8+26 more
Mayo Clinic
Testing effectiveness (Phase 2)Study completedNCT02760030
What this trial is testing

Endocrine Therapy Fulvestrant & Palbociclib or Aromatase Inhibitor Therapy in Treating Older Patients With Hormone Responsive Breast Cancer That Cannot Be Removed by Surgery

Who this might be right for
Estrogen Receptor and/or Progesterone Receptor PositiveHER2/Neu NegativeStage IA Breast Cancer+6 more
Ohio State University Comprehensive Cancer Center 14
Testing effectiveness (Phase 2)Study completedNCT00046371
What this trial is testing

Safety and Immunological Response Rate Study of THERATOPE® Vaccine in Metastatic Breast Cancer Patients

Who this might be right for
Breast Neoplasms
Oncothyreon Canada Inc.
Testing effectiveness (Phase 2)Study completedNCT03477396
What this trial is testing

Ribociclib and Aromatase Inhibitor in Treating Older Participants With Hormone Receptor Positive Metastatic Breast Cancer

Who this might be right for
Estrogen Receptor and/or Progesterone Receptor PositiveHER2/Neu NegativeStage IV Breast Cancer AJCC v6 and v7
City of Hope Medical Center 2
Not applicableLooking for participantsNCT07256769
What this trial is testing

Vitamin k, D-chiro Inositol and α-lactalbumin in Bone Homeostasis

Who this might be right for
Osteoporosis SecondaryBreast Cancer Females
Regina Elena Cancer Institute 134
Large-scale testing (Phase 3)Active Not RecruitingNCT02918084
What this trial is testing

CONcurrent vs SEqueNTial Adjuvant Treatments in Early Breast Cancer

Who this might be right for
Breast Cancer
IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy 1,000
Not applicableStudy completedNCT01431872
What this trial is testing

Systemic Dickkopf-related Protein 1 (DKK1)During Estrogen Level Changes in Post-menopausal Breast Cancer Patients Treated With Aromatase Inhibitors

Who this might be right for
Breast Cancer
University of Arkansas 17
Not applicableStudy completedNCT03318263
What this trial is testing

CIrCuLAting Dna ESr1 Gene Mutations Analysis

Who this might be right for
Breast Cancer
Institut de Cancérologie de Lorraine 146
Next Page